ATOM STEM CELLS

Call Directions Website Contact the practice

ATOM STEM CELLS ATOM is the complete stem cell partner for clinics, med spas, and IV shops. We don't just sell you product.

We give you the training to deliver it and the marketing systems to get patients through the door.

Freezing a living cell isn't just making it cold.Water expands when it freezes. Ice that forms inside or around a cell c...
10/14/2026

Freezing a living cell isn't just making it cold.

Water expands when it freezes. Ice that forms inside or around a cell can rupture its membrane.

So labs cool slowly. Slow, controlled cooling pulls water out of the cell before it freezes. Less ice inside. But that creates a second problem. The cell now sits in a concentrated, dehydrating environment as the water around it freezes out.

Every freezing protocol is a balance between those two kinds of damage.

The basic process:
▫️ Cryoprotectant. The cells are suspended in a medium designed to limit ice damage.
▫️ Controlled-rate cooling. Cooled at a defined rate, often in a rate-controlled freezer.
▫️ Long-term storage. Usually vapor-phase liquid nitrogen, where biological activity is effectively suspended.
▫️ Cold-chain shipment. A temperature excursion in transit can reduce post-thaw viability.
▫️ Thaw. Technique and time-to-administration both affect the final viable count.

"Why should I care how my supplier freezes cells?" Because every step is a place cells can be lost. That's why a viability number only means something if it was measured after the full cycle. Freeze, storage, shipment, and thaw.

ATOM products are frozen in a DMSO-free, chemically defined medium and ship overnight under temperature-controlled cold chain. Post-thaw viability is measured on the actual lot after the full freeze-to-thaw cycle, by an independent third-party lab. Not projected from a pre-freeze sample.

The process, step by step: atomstemcells.com/learn/how-stem-cells-are-cryopreserved

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

"Twenty billion particles per mL."Sounds impressive. It isn't a potency result.A particle count tells you how many thing...
10/14/2026

"Twenty billion particles per mL."

Sounds impressive. It isn't a potency result.

A particle count tells you how many things a machine saw. Not what they do.

Potency means something specific. A defined biological activity, measured with a validated assay.

Here's the problem with leaning on counts. Particle counters can't tell vesicles from other particles in the same size range. Most of what gets counted may not be vesicles at all. And identity and integrity tests, useful as they are, may not predict potency either.

"So has anyone figured this out?" Honest answer: not fully. The science is still unsettled. That's exactly why the questions matter.

Before you trust any exosome sheet, ask:
▫️ What was measured?
▫️ How was it measured?
▫️ Who ran the test?
▫️ Is the result tied to the lot in your hand?

The new post on the ATOM blog draws on Gimona 2021, Witwer 2019, and the MISEV guidelines. It covers what researchers say real potency testing has to measure, what common tests do and don't show, and six questions to ask any supplier: atomstemcells.com/post/exosome-potency-testing

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

Show me the count.Not a number on a spec sheet. Not a line in a sales email. The count itself.Most doctors never ask for...
10/14/2026

Show me the count.

Not a number on a spec sheet. Not a line in a sales email. The count itself.

Most doctors never ask for this. Most suppliers never offer it. Anyone can type "millions of cells per mL" into a PDF. Watching the cells get counted is a different thing.

So we put one out there. A recorded live cell count of ATOM MUSE is published on our products page. You can watch it.

Why it's worth asking for:
▫️ A number on a page is a claim.
▫️ A count you can watch shows how the number was made.
▫️ A lot-specific COA ties the viable cell count and post-thaw viability, with the method, to the lot number on your vial.

"Isn't a video just marketing too?" Fair question. A video shows one count, on one day. It doesn't replace the COA for your lot. That's why you want both. The video shows you the process. The COA tells you what was measured in the vial you're holding.

Ask any supplier for the same thing. If they can't show it, ask why.

Watch the count: atomstemcells.com/products

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

Inside the lab. A cord tissue sample and media, on ice.That jar holds human tissue. That one fact decides which rulebook...
10/13/2026

Inside the lab. A cord tissue sample and media, on ice.

That jar holds human tissue. That one fact decides which rulebook applies.

Products made from human cells or tissue are called HCT/Ps: human cells, tissues, and cellular and tissue-based products. In the US, they fall under 21 CFR Part 1271.

Part 1271 covers things like facility registration, donor eligibility, and current good tissue practice.

Here's where a lot of doctors get tripped up.

HCT/P is a classification. It isn't an approval. Being subject to Part 1271 doesn't mean the FDA approved anything. The source doesn't change that either. Umbilical cord or bone marrow, neither one confers FDA approval by itself.

"So who confirms the regulatory status for my use?" You do. The ordering provider is responsible for verifying that their license, scope of practice, and applicable law permit the intended use. A supplier can hand you documents. It can't take that job off your desk.

Questions worth asking any supplier:
▫️ How is this product classified, and what is that based on?
▫️ Is the facility registered, and do you say plainly that registration isn't approval?
▫️ What documents come with each lot?

Then run the answers past your own regulatory counsel.

ATOM products are HCT/Ps subject to 21 CFR Part 1271, made at an FDA-registered facility under cGMP-compliant conditions. "FDA-registered" refers to facility registration only. Not approval, clearance, or endorsement.

Want to see the documents that ship with a lot? Ask the ATOM team: atomstemcells.com/contact

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

243 clinic websites. Read line by line.That's what Murdoch, Zarzeczny and Caulfield did for a 2018 paper in BMJ Open. Th...
10/13/2026

243 clinic websites. Read line by line.

That's what Murdoch, Zarzeczny and Caulfield did for a 2018 paper in BMJ Open. They reviewed sites marketing stem cell therapies and counted what was said. And what wasn't.

What they reported:
▫️ 24.7% mentioned general procedure risks.
▫️ 5.8% mentioned risks specific to the therapy.
▫️ 33.3% said the therapy was experimental or unproven.
▫️ 31.7% used hype words like "breakthrough" and "revolutionary."
▫️ MDs appeared on more than half the sites.

Put those together. A physician on the page. And on about 94 of every 100 sites, not one therapy-specific risk.

This isn't a small corner of the field. In 2016, Turner and Knoepfler counted 351 US businesses, with 570 clinics, marketing stem cell interventions directly to consumers.

"If I talk straight about what's unknown, won't I lose patients?"

Maybe some. People who want a promise will go find someone who makes one. That's not a reason to make one. Your name ends up on the chart. The copywriter's doesn't.

The full post gives 5 steps for an honest patient conversation: what it is, what the evidence shows and doesn't, the risks, the words to cut, and the lot documents to show. Plus a word-swap table you can hand to whoever writes your website.

Read it here: atomstemcells.com/post/stem-cell-marketing-for-doctors

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

"Our cells test at 95% viability."Which cells? Which lot? Measured when?A lot of what doctors get sent is a spec sheet. ...
10/13/2026

"Our cells test at 95% viability."

Which cells? Which lot? Measured when?

A lot of what doctors get sent is a spec sheet. One page. Clean numbers. No lot number. Sometimes the numbers come from an example batch. That's fine as an example. It isn't your lot.

Here's the plain rule: a number without a lot is a marketing claim.

A lot-specific COA ties every result to one lot:
▫️ A lot number that matches the one on your vial.
▫️ Viable cell count and post-thaw viability, with the method.
▫️ Identity and sterility results for that lot.
▫️ A dated release with a named, credentialed signatory.

"My supplier's spec sheet is accurate." It might be. A spec sheet tells you what a supplier aims for. A lot COA tells you what was measured in the vial you're holding. You want the second one.

Every ATOM unit ships with a lot-specific COA. The lot number on the COA matches the one stamped on the vial, and post-thaw viability is tested by an independent third-party lab.

The full list of what belongs on a COA: atomstemcells.com/learn/what-should-be-on-a-coa

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

Inflammation is a signal.Before it's anything else, it's information. Tissue sends it. Immune cells read it and respond....
10/12/2026

Inflammation is a signal.

Before it's anything else, it's information. Tissue sends it. Immune cells read it and respond.

That framing matters if you want to understand what MSCs are studied for.

In lab research, much of what MSCs do is now thought to happen through what they release, not through the cells turning into new tissue. That release is called the secretome:
▫️ Cytokines. Small signaling proteins.
▫️ Growth factors.
▫️ Extracellular vesicles, including exosomes, which carry proteins, lipids, mRNA, and microRNA.

In experiments, studies have reported that these secreted signals interact with immune cells such as macrophages and T cells, and can change how those cells behave.

"Does that mean the same thing happens in a patient?" Nobody can promise that. Lab findings are lab findings. They help explain the biology. They don't predict any result.

What you can control is knowing what's in the vial. For cells, ask for the viable cell count and post-thaw viability, with the method. For exosomes, ask for particle concentration and size, with the method. Both tied to the lot in your hand.

Want to go deeper on the science, or check a specific lot? Ask the ATOM team: atomstemcells.com/contact

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

"Wharton's jelly."Two words on a label. A lot of doctors read them as a spec. They aren't.Wharton's jelly is the gel-lik...
10/12/2026

"Wharton's jelly."

Two words on a label. A lot of doctors read them as a spec. They aren't.

Wharton's jelly is the gel-like tissue around the vessels in the umbilical cord. It isn't cord blood. Reviews describe cells from it as meeting the 2006 ISCT definition of an MSC. Whether they act as true stem cells in the body is still being studied.

Here's the part most sales sheets skip.

Researchers describe distinct zones inside the jelly: subamnion, intermediate, perivascular, and intervascular. A 2017 review (Davies, Walker and Keating) reported little consensus on how to define those zones or how to extract cells from them. The authors called for transparency about extraction methods.

Extraction method can change which cells get collected. So "Wharton's jelly" on a label is a starting point. Not a specification.

"So how do I know what's in the vial?" The label won't tell you. Lot-specific documents will:
▫️ Identity markers, with real percentages.
▫️ Viable cell count.
▫️ Post-thaw viability, with the method named.
▫️ All of it tied to the lot number on your vial.

The photo: cord tissue pieces going into culture flasks, inside the lab.

The 5 questions to ask any supplier are in the full post: atomstemcells.com/post/whartons-jelly-stem-cells

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

Inside the lab. Step one.Umbilical cord tissue, on ice, before any processing starts.It doesn't look like much. But this...
10/12/2026

Inside the lab. Step one.

Umbilical cord tissue, on ice, before any processing starts.

It doesn't look like much. But this is where the paper trail begins.

Every vial that reaches your clinic has a history. Where the tissue came from. How the donor was screened. Who handled it, when, and at what temperature. That record is called chain of custody.

Why should you care? A COA tells you what was measured on a lot. Chain of custody tells you the lot in your hand is the one that was measured.

Three questions for any supplier:
▫️ Where did this lot's tissue come from, and how was the donor screened?
▫️ Is there a chain-of-custody record for this lot?
▫️ Was the cold chain documented all the way to your door?

"Isn't that the supplier's problem?" It is, right up until the vial is in your hand and your name is on the chart.

Every ATOM box ships with a lot-specific COA, chain-of-custody records, and overnight cold-chain packaging. Real cells leave a paper trail.

See what's in an ATOM box: atomstemcells.com/proof

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

"92% viable."When? Before freezing, or after thawing?That one detail matters more than the number. A cell that was alive...
10/11/2026

"92% viable."

When? Before freezing, or after thawing?

That one detail matters more than the number. A cell that was alive before it was frozen isn't necessarily alive after it's thawed.

Here's what can lower post-thaw viability between the lab and your syringe:
▫️ Freeze rate. How fast the cells were cooled.
▫️ Cryoprotectant. What the cells were frozen in.
▫️ Cold chain. Any temperature excursion in transit.
▫️ Thaw technique, and the time from thaw to administration.
▫️ Cell type. Some cells handle freezing better than others.

"My supplier says their cells freeze fine." Maybe they do. Ask them to show you. A viability figure taken before freezing tells you almost nothing about what ends up in the syringe.

The question to ask: "What is the post-thaw viable cell count for this specific lot, and what method was used to measure it?"

ATOM's release specification is 95% post-thaw viability, documented per lot on a lot-specific COA, with testing by an independent third-party lab.

The five factors, explained in plain English: atomstemcells.com/learn/post-thaw-viability

For licensed healthcare providers only. ATOM products are not FDA-approved or cleared and are not intended to diagnose, treat, cure, mitigate, or prevent any disease. Provider-directed use only.

Address

9830 W. Tropicana Avenue STE 165
Las Vegas, NV
89147

Telephone

+14352222621

Website

Alerts

Be the first to know and let us send you an email when ATOM STEM CELLS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ATOM STEM CELLS:

Shortcuts

Sponsored

Share

Category